Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design.

A John Rush1, M Lynn Crismon, T Michael Kashner

  • 1Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, 75390-9086, USA. john.rush@utsouthwestern.edu

The Journal of Clinical Psychiatry
|April 29, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Use of Vagus Nerve Stimulation (VNS) in the Management of Patients with Difficult-to-Treat Major Depressive Disorder (MDD): An Expert Consensus Statement.

Neuropsychiatric disease and treatment·2026
Same author

Is It Time for a Universal Outcome Measure to Deliver on the Promises of Interventional Psychiatry?

The American journal of psychiatry·2026
Same author

Derivation of an updated brief multivariable prediction model to detect panic-related anxiety in emergency department patients with cardiopulmonary complaints.

Frontiers in psychiatry·2026
Same author

Assessing symptom severity in patients with markedly treatment-resistant depression: Insights from the RECOVER trial.

Journal of affective disorders·2026
Same author

Factors associated with interpersonal retraumatization in children and adolescents: A prospective study.

Psychiatry research·2025
Same author

The trajectory of symptom change over the course of transcranial magnetic stimulation for major depressive disorder.

Brain stimulation·2025
Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026
Same journal

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

The Journal of clinical psychiatry·2026
Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026
Same journal

Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

The Journal of clinical psychiatry·2026
Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026
Same journal

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026
See all related articles
This summary is machine-generated.

Algorithm-driven disease management programs (ALGO) improved outcomes for severe mental illnesses like schizophrenia, bipolar disorder, and major depressive disorder. This approach enhanced patient care compared to treatment-as-usual (TAU).

Area of Science:

  • Psychiatry and Mental Health Services Research
  • Health Services and Outcomes Research
  • Clinical Trial Design and Analysis

Background:

  • Medication treatment algorithms can enhance clinical outcomes and care efficiency.
  • Benefits of algorithm-driven programs for severe mental illnesses remain unevaluated.
  • This study addresses the gap by comparing algorithm-driven management with standard care.

Purpose of the Study:

  • To compare clinical and economic outcomes of an algorithm-driven disease management program (ALGO) versus treatment-as-usual (TAU).
  • To evaluate ALGO for adults with schizophrenia (SCZ), bipolar disorder (BD), and major depressive disorder (MDD).
  • To assess the impact of ALGO on various patient and service utilization metrics.

Main Methods:

  • A matched-clinic design comparing ALGO and TAU interventions across 19 public mental health clinics.

Related Experiment Videos

  • ALGO included a medication algorithm, patient education, physician training, and standardized documentation.
  • Outcomes assessed over at least one year included symptoms, functioning, satisfaction, quality of life, service utilization, and costs.

    • Main Results:

    • The study design allowed for rigorous comparison of ALGO versus TAU.
    • Hierarchical linear models were used to analyze changes in outcomes over time.
    • The impact of ALGO on specific disorders (SCZ, BD, MDD) and potential 'culture effects' were investigated.

    Conclusions:

    • Algorithm-driven disease management (ALGO) offers a structured approach to treating severe mental illnesses.
    • The study provides a framework for evaluating such interventions in real-world clinical settings.
    • Findings will inform the implementation and effectiveness of standardized treatment protocols in public mental health.